(Q54029811)

23 May 2018

title

Impact of better adherence to statin agents in the primary prevention of coronary artery disease. (English)

1 reference

23 May 2018

4

Anick Bérard

1 reference

23 May 2018

Lyne Lalonde

5

object named as

Lyne Lalonde

1 reference

23 May 2018

Lucie Blais

3

object named as

Lucie Blais

1 reference

23 May 2018

author name string

Sylvie Perreault

1

1 reference

23 May 2018

Alice Dragomir

2

1 reference

23 May 2018

Michel White

6

1 reference

23 May 2018

Danielle Pilon

7

1 reference

23 May 2018

publication date

16 June 2009

1 reference

23 May 2018

European Journal of Clinical Pharmacology

published in

1 reference

23 May 2018

volume

65

1 reference

23 May 2018

issue

10

1 reference

23 May 2018

page(s)

1013-1024

1 reference

23 May 2018

https://scigraph.springernature.com/pub.10.1007/s00228-009-0673-0

exact match

0 references

cites work

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0673-0

Mortality over a period of 10 years in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0673-0

Heart failure in the general population of men--morbidity, risk factors and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0673-0

Confounding by indication: an example of variation in the use of epidemiologic terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0673-0

A meta-analysis of the association between adherence to drug therapy and mortality

21 January 2018

1 reference

12 December 2020

A chronic disease score from automated pharmacy data

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Coronary heart disease risk factors ranked by importance for the individual and community. A 21 year follow-up of 12 000 men and women from The Copenhagen City Heart Study

1 reference

12 December 2020

Impact of adherence to statins on coronary artery disease in primary prevention

1 reference

12 December 2020

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

12 December 2020

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

12 December 2020

Validation of diagnostic codes within medical services claims

1 reference

12 December 2020

Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment

1 reference

12 December 2020

Sensitivity analysis, Monte Carlo risk analysis, and Bayesian uncertainty assessment.

1 reference

12 December 2020

Epidemiology, aetiology, and prognosis of heart failure

1 reference

12 December 2020

Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy

1 reference

12 December 2020

Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients

1 reference

12 December 2020

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

12 December 2020

Current and future directions of cardiovascular risk prediction

1 reference

12 December 2020

Adherence to Medication

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure

1 reference

12 December 2020

Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2)

1 reference

12 December 2020

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention

1 reference

12 December 2020

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

12 December 2020

C-reactive protein levels and outcomes after statin therapy

1 reference

12 December 2020

Approximate equivalent rosuvastatin doses for temporary statin interchange programs

1 reference

12 December 2020

Lifetime risk of coronary heart disease by cholesterol levels at selected ages

1 reference

12 December 2020

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

1 reference

12 December 2020

Methods for evaluation of medication adherence and persistence using automated databases

1 reference

12 December 2020

Biased Selection of Controls for Case-Control Analyses of Cohort Studies

1 reference

12 December 2020

Cardiovascular disease on a global scale: defining the path forward for research and practice

1 reference

12 December 2020

Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992.

1 reference

12 December 2020

The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec

1 reference

12 December 2020

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

12 December 2020

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

Incidence and epidemiology of heart failure

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

12 December 2020

A checklist for medication compliance and persistence studies using retrospective databases.

1 reference

12 December 2020

Long-term persistence in use of statin therapy in elderly patients

1 reference

12 December 2020

Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA).

1 reference

12 December 2020

Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer.

1 reference

12 December 2020

Discontinuation of statin therapy following an acute myocardial infarction: a population-based study

1 reference

12 December 2020

Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study).

1 reference

12 December 2020

10.1007/S00228-009-0673-0

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

19529927

1 reference

23 May 2018